Recherche
-
Travel-related infections presenting in Europe: A 20-year analysis of EuroTravNet surveillance data
(The Lancet Regional Health - Europe. vol. 1, pp. 100001, 2021-02)Article de revueLibre accès -
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
(Antiviral Research. vol. 193, pp. 105137, 2021-07-12)Article de revueLibre accès -
Maternal Infection and Adverse Pregnancy Outcomes among Pregnant Travellers: Results of the International Zika Virus in Pregnancy Registry
(Viruses. vol. 13, n° 2, 2021-02-22)Article de revueLibre accès -
Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study
(Journal of Clinical Virology. vol. 141, pp. 104878, 2021-06-05)Article de revueLibre accès -
Depression and anxiety symptoms in young adults before and during the COVID-19 pandemic: evidence from a Canadian population-based cohort
(Annals of General Psychiatry. vol. 20, n° 1, pp. 42, 2021-09-08)Article de revueLibre accès -
Trabectedin plus durvalumab in patients with advanced pretreated soft tissue sarcoma and ovarian carcinoma (TRAMUNE): an open-label, multicenter phase Ib study
(Clinical Cancer Research, 2021-12-29)Article de revue -
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysis
(HIV Medicine, 2021-08-17)Article de revueLibre accès -
Randomized trial to evaluate the safety and efficacy of outpatient treatments in individuals with Covid-19 with risk factors. COVERAGE France Trial: a structured summary
(Exercer. vol. 178, pp. 451-458, 2021-12)Article de revue -
Chronic viral hepatitis, HIV infection and Non-Hodgkin Lymphomas in West Africa, a case-control study
(International Journal of Cancer. vol. 149, n° 8, pp. 1536-1543, 2021-06-14)Article de revue -
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
(Science Immunology. vol. 6, n° 62, 2021-08-19)Article de revueLibre accès